Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis

Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis

Plasma collected from people recovered from COVID-19 (COVID-19 convalescent plasma, CCP) was the first antibody-based therapy employed to fight the pandemic. CCP was, however, often employed in combination with other drugs, such as the antiviral remdesivir and glucocorticoids. The possible effect of...

Full description

Bibliographic Details
Main Authors: Massimo Franchini, Daniele Focosi, Mario Cruciani, Michael J. Joyner, Liise-anne Pirofski, Jonathon W. Senefeld, Shmuel Shoham, David J. Sullivan, Arturo Casadevall
Format: Article
Language:English
Published: MDPI AG 2024-02-01
Series:Diseases
Subjects:
COVID-19
SARS-CoV-2
convalescent plasma
remdesivir
steroids
combined therapy
Online Access:https://www.mdpi.com/2079-9721/12/3/41

Internet

https://www.mdpi.com/2079-9721/12/3/41

Similar Items